Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Fortune: Big Pharma’s new CEOs must step up to erase inequities in drug access

In this opinion piece for Fortune, Executive Director Jayasree K. Iyer assesses the power of pharmaceutical company CEOs to drive progress in their industry when it comes to access to medicine. 

Date

15 December 2020

Direct links

Read the viewpoint

"I have been asked many times: Does the vision of the CEO have the power to change a pharmaceutical company so it can solve global health challenges? 

My answer is “yes.” The power of a top drug industry executive to change the global healthcare landscape is real. On the downside, he or she can cause plenty of damage by adopting the wrong policies. But if they are truly willing to make the radical changes that this industry desperately needs, they can also make a big difference for the good."

The article continues here on Fortune.com.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved